52
Participants
Start Date
January 31, 2015
Primary Completion Date
June 30, 2017
Study Completion Date
June 30, 2017
Dexmedetomidine
As a loading dose, 0.5 μg/kg dexmedetomidine was administered over 10 min, which was then administered continuously at a dose of 0.2-0.8 μg/kg/h. Sedation was maintained at modified observer's assessment of alertness/sedation scale 3
Propofol
Propofol was infused continuously via a target-controlled infusion device, and the effect-site concentration was maintained with a range of 0.5-2.0 μg/ml. Sedation was maintained at modified observer's assessment of alertness/sedation scale 3
Seoul National University Bundang Hospital, Seongnam-si
Seoul National University Bundang Hospital
OTHER